Hematological Malignancies

• RT: 67 pts (66%)

• 102 patients with primary bone DLBCL • median age: 55 years (range, 16-87 years) • most common site of presentation: long bones

 47 pts stage I – II  20 pts stage III – IV

• median RT dose: 44 Gy

Tao et al, IJROBP, 2015